首页> 外文期刊>New scientist >Therapeutic cloning set back by hype and fraud
【24h】

Therapeutic cloning set back by hype and fraud

机译:治疗性克隆因炒作和欺诈而退缩

获取原文
获取原文并翻译 | 示例
           

摘要

Just a year ago, the prospects for "therapeutic" cloning seemed bright. The idea is to create an embryo by inserting the nucleus of a patient's cell into a human egg stripped of its own genetic material. The embryo, genetically matched to the original patient, would be grown for a few days to create a hollow ball of cells called a blastocyst. Embryonic stem cells (ESCs), which have the potential to turn into any type of tissue in the body, would then be extracted from it. So in May 2005, when Woo Suk Hwang of Seoul National University in South Korea claimed that he had created 11 different lines of cloned human ESCs in this way, the goal of treating patients with tissues genetically matched to their own cells seemed to be within reach. Now, with Hwang revealed as a fraud, we are back to square one: no one has yet created a single line of cloned human ESCs. But for groups that are planning to try there are some reasons for optimism.
机译:就在一年前,“治疗性”克隆的前景似乎一片光明。这个想法是通过将患者细胞核插入剥离了自身遗传物质的人卵中来创建胚胎。基因与原始患者遗传匹配的胚胎将生长几天,以产生一个称为囊胚的空心细胞球。胚胎干细胞(ESCs)可能会转化为体内任何类型的组织,然后将其提取出来。因此,在2005年5月,韩国首尔国立大学的Woo Suk Hwang声称以这种方式创建了11种不同的克隆人类ESC细胞系时,治疗具有与自身细胞基因匹配的组织的患者的目标似乎可以实现。现在,黄某被揭露为欺诈,我们回到正题:没有人创建一行克隆的人类ESC。但是对于计划尝试的小组,有些理由感到乐观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号